Modular and Digitised Pharma Production

Dividella is working with Medipak Systems sister companies to find new answers to the question of what does modularity offer in the digitisation of industrial production.

Digitisation, including the use of big data and interconnectivity, has considerable potency in generating sustainable competitive advantages for the pharmaceutical industry, particularly in embracing Industry 4.0 design philosophies.

However, to take maximum advantage of smart technologies means embracing modular approach at every level from design concepts to engineering, construction and processes. This is essential to fully exploit the connectivity and data-sharing that are inherent parts of the Industry 4.0 concept and its Pharma 4.0 derivative.